Health
4 years ago

WHO halts trial of malaria drug hydroxychloroquine in COVID-19 patients

A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease (COVID-19) in Liege, Belgium, June 16, 2020. Reuters
A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease (COVID-19) in Liege, Belgium, June 16, 2020. Reuters

Published :

Updated :

For all latest news, follow The Financial Express Google News channel.

The World Health Organisation said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit, reports Reuters.

"The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.

Share this news

More News